Kardigan
↗South San Francisco, USA
Kardigan is a patient-driven, cardiovascular-focused biotechnology company dedicated to modernizing drug development to move patients beyond symptom management toward functional cures. The company utilizes a proprietary 'Cardiac Intelligence' platform that integrates clinical trial data, real-world patient insights, and advanced analytics to match disease drivers with treatment responders.
Founded by veterans of MyoKardia, Kardigan employs a dual strategy of internal R&D and strategic in-licensing to build a portfolio of targeted therapies. Following its acquisition of Prolaio in 2025, the company has significantly enhanced its ability to leverage digital health tools and high-density clinical data to streamline the development of medicines for conditions such as genetic dilated cardiomyopathy, calcific aortic valve stenosis, and acute severe hypertension.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Biotechnology
Sub-Industry:Cardiovascular therapeutics
SIZE & FINANCIALS
Employees:51-200
Founded:2023
Ownership:private
Status:operating
FUNDING
Stage:Series B
Total Raised:$554M
Investors:Perceptive Advisors, ARCH Venture Partners, Sequoia Heritage, Fidelity Management & Research Company, T. Rowe Price Investment Management
PIPELINE
Stage:Phase 2/3
Lead Drug Stage:Phase 3
Modalities:Small molecule, ASO
Active Trials:2
Trial Phases:Phase 2: 1 | Phase 3: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Prolaio
Key Partnerships:Bristol Myers Squibb (licensing), Ionis Pharmaceuticals (licensing), Sanofi (licensing), Mayo Clinic (licensing)
COMPETITION
Position:Emerging
Competitors:Cardurion Pharmaceuticals, Cytokinetics
LEADERSHIP
Key Executives:
Tassos Gianakakos - CEO and Chair
Jay Edelberg - Chief Medical Officer
Bob McDowell - Chief Scientific Officer
Scientific Founders:Tassos Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, Beth McNally
Board Members:Tassos Gianakakos, Paul Berns, Doug Giordano, David Meeker, Kim Popovits
LINKS
Website:kardigan.bio
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Kardigan and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Kardigan. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.